Suchergebnisse - "Schetelig, J"

PubPharm (91)

31

Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation – a pilot study

enthalten in: European journal of cancer care / English language edition | 2016

von Schuler, M. | Hornemann, B. | Pawandenat, C. | +10

32

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

enthalten in: Bone marrow transplantation | 2016

von van Gelder, M. | de Wreede, L. | Bornhäuser, M. | +27

33

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

enthalten in: Bone marrow transplantation | 2016

von van Gelder, M. | de Wreede, L. | Bornhäuser, M. | +27

34

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Thiel, A. | Schetelig, J. | Pönisch, W. | +19

35

Hematopoietic cell transplantation in patients with intermediate and high-risk AML : results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

enthalten in: Leukemia | 2015

von Schetelig, J. | Schaich, M. | Schäfer-Eckart, K. | +23

36

Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema

enthalten in: Translational research : the journal of laboratory and clinical medicine | 2015

von Shayegi, N. | Alakel, N. | Middeke, J. | +3

37

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

enthalten in: Leukemia | 2015

von Schetelig, J. | Schaich, M. | Schäfer-Eckart, K. | +22

38

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

enthalten in: Leukemia | 2015

von Middeke, J. | Herbst, R. | Parmentier, S. | +23

39

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

enthalten in: Annals of oncology | 2015

von Thiel, A. | Schetelig, J. | Pönisch, W. | +17

40

Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study

enthalten in: European journal of cancer care / English language edition | 2015

von Schuler, M. | Hornemann, B. | Pawandenat, C. | +10